California legalized recreational cannabis for adults in 2016, and that has led many people to assume the substance is harmless for everyone. The reality is more nuanced. Cannabis can cause a real use disorder for a significant minority of people who use it regularly, and in a state where the substance is widely and legally available, understanding the risks matters. This article is general education and is not a substitute for professional medical advice.
Cannabis use disorder (CUD) is a recognized medical condition. According to the National Institute on Drug Abuse (NIDA), approximately 9 percent of people who use marijuana will develop dependence on it — a figure that rises to about 17 percent among those who begin in adolescence and to roughly 25 to 50 percent among daily users. Dependence means the brain has adapted to the drug’s presence; stopping can then produce withdrawal symptoms. CUD is diagnosed using criteria similar to those for other substance use disorders: using more than intended, being unable to cut back despite wanting to, spending significant time obtaining or using, continuing despite harm, and giving up previously enjoyed activities in order to use.
Because cannabis is legal and widely socially accepted in California, the line between casual and problematic use can be easy to miss. Common signs include:
MedlinePlus notes that cannabis withdrawal symptoms — including irritability, mood swings, sleep difficulty, decreased appetite, and restlessness — typically begin within days of stopping regular use and are generally not life-threatening, though they can be uncomfortable enough to drive a return to use without support.
The Centers for Disease Control and Prevention (CDC) describes several concerns associated with cannabis, including effects on brain development in young people (the brain continues maturing until around age 25), respiratory effects from smoke inhalation, and the risk of Cannabis Hyperemesis Syndrome, a condition of cyclic severe vomiting linked to prolonged heavy use. Heavy use is also associated with increased risk of anxiety and depression, and in people with a genetic predisposition, with psychotic disorders.
Potency is an important factor NIDA highlights: THC concentrations in commercially available products have risen sharply in recent decades. High-potency concentrates, vape cartridges, and edibles can deliver much larger doses than older forms of the drug, sometimes faster than users realize, and higher potency is linked to greater risk of dependence and adverse mental health effects.
One of the most clinically important patterns is how often CUD co-occurs with anxiety, depression, PTSD, or other mental health conditions. Many people use cannabis to cope with difficult emotions, and while it may offer short-term relief, heavy regular use often deepens anxiety and low mood over time. Treating only the cannabis use while leaving an underlying mental health condition unaddressed rarely produces lasting results. Our integrated dual diagnosis treatment addresses both conditions with one coordinated team, which research consistently supports as the more effective approach.
There is currently no FDA-approved medication specifically for cannabis use disorder, but effective behavioral treatments exist. SAMHSA and NIDA both support behavioral therapies including cognitive behavioral therapy (CBT), motivational enhancement therapy, and contingency management as approaches with strong evidence for CUD. These help people understand triggers and use patterns, strengthen motivation to change, build coping skills for cravings, and develop routines that support a cannabis-free life. Many people do well in outpatient settings, which can be structured around work and family. Our outpatient treatment programs provide therapeutic structure without requiring time away from daily responsibilities. For those with more severe use, co-occurring conditions, or an unstable home environment, more intensive care may be recommended following a clinical assessment.
Young people are at greater risk of developing cannabis use disorder and of experiencing lasting effects on brain development. The CDC notes that cannabis use during adolescence may affect attention, memory, and learning. If a young person in your family is using cannabis heavily, a clinical evaluation from a provider experienced in adolescent substance use is a meaningful first step.
Cannabis use disorder is a real, treatable medical condition, and reaching out for help is a sign of strength. California Treatment Centers is in-network with most major insurers and has multiple locations across California. We offer free, confidential insurance verification so you can understand your coverage with no obligation. Call 213-321-6518. For free, confidential, 24/7 support and treatment referrals, you can also reach the SAMHSA National Helpline at 1-800-662-4357. If you or a loved one is in crisis or having thoughts of suicide, call or text the 988 Suicide & Crisis Lifeline.
We're in-network with most major insurers. We confirm your benefits and report back, usually within a few hours. HIPAA & 42 CFR Part 2 protected.
Call 213-321-6518